Statin-mediated correction of STAT1 signaling and inducible nitric oxide synthase expression in cystic fibrosis epithelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 6 29-6, 2003, Pages

  Kreiselmeier, Norman E ^a   Kraynack, Nathan C ^a   Corey, Deborah A ^a   Kelley, Thomas J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

GTPase; Isoprenoid; Mevastatin; Protein inhibitor of activated signal transducer and activator of transcription 1; RhoA

Indexed keywords

CHOLESTEROL; COMPACTIN; ISOPRENOID; NITRIC OXIDE SYNTHASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INDUCTION; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION;

EID: 0345358534     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00127.2003     Document Type: Article

References (33)

1. Backlund PS. Post-translational processing of RhoA. J Biol Chem 272: 33175-33180, 1997.
2. Boujaoude LC, Bradshaw-Wilder C, Mao C, Cohn J, Ogretmen B, Hannun YA, and Obeid LM. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 276: 35258-35264, 2001.
3. Bryan R, Kube D, Perez A, Davis P, and Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol 19: 269-277, 1998.
4. Dotsch J, Puls J, Klimek T, and Rascher W. Reduction of neuronal and inducible nitric oxide synthase gene expression in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 259: 222-226, 2002.
5. Eidelman O, Srivastava M, Zhang J, Leighton X, Murtie J, Jozwik C, Jacobson K, Weinstein DL, Metcalf EL, and Pollard HB. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway. Mol Med 7: 523-534, 2001.
6. Estell K, Braunstein G, Tucker T, Varga K, Collawn JF, and Schwiebert LM. Plasma membrane CFTR regulates RANTES expression via its C-terminal PDZ-interacting motif. Mol Cell Biol 23: 594-606, 2003.
7. Huang S, Chen LY, Zuraw BL, Ye RD, and Pan ZK. Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA. J Biol Chem 276: 40977-40981, 2001.
8. Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, and Nawata H. A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J Hepatol 32: 762-770, 2000.
9. Kahyo T, Nishida T, and Yasuda H. Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol Cell 8: 713-718, 2001.
10. Kelley TJ and Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 102: 1200-1207, 1998.
11. Kelley TJ, Elmer HL, and Corey DA. Reduced Smad3 protein expression and altered transforming growth factor-betal-mediated signaling in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 25: 732-738, 2001.
12. Kelley TJ and Elmer HL. In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. J Clin Invest 106: 403-140, 2000.
13. Kraynack NC, Corey DA, Elmer HL, and Kelley TJ. Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 283: L604-L611, 2002.
14. Kube D, Sontich U, Fletcher D, and Davis PB. Proinflammatory cytokine responses to P. aeruginosa infection in human airway epithelial cell lines. Am J Physiol Lung Cell Mol Physiol 280: L493-L502, 2001.
15. Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD, and Shuai K. Inhibition of Stat1-mediated gene activation by PIAS1. Proc Natl Acad Sci USA 95: 10626-10631, 1998.
16. Megidish T, Xu JH, and Xu CW. Activation of p53 by protein inhibitor of activated Statl (PIAS1). J Biol Chem 277: 8255-8259, 2002.
17. Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, Gruenert DC, Gyi KM, Hodson ME, Yacoub MH, and Polak JM. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 184: 323-331, 1998.
18. Morrissey BM, Schilling K, Weil JV, Silkoff PE, and Rodman DM. Nitric oxide and protein nitration in the cystic fibrosis airway. Arch Biochem Biophys 406: 33-39, 2002.
19. Muniyappa R, Xu R, Ram JL, and Sowers JR. Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 278: H1762-H1768, 2000.
20. Schmidt D and Muller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 99: 2872-2877, 2002.
21. Schmitz G and Buechler C. ABCA1: regulation, trafficking and association with heteromeric proteins. Ann Med 34: 334-347, 2002.
22. Schwiebert LM, Estell K, and Propst SM. Chemokine expression in CF epithelia: implications for the role of CFTR in RANTES expression. Am J Physiol Cell Physiol 276: C700-C710, 1999.
23. Shepard LW, Yang M, Xie P, Browning DD, Voyno-Yasenetskaya T, Kozasa T, and Ye RD. Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi's sarcoma-associated herpes virus involve G alpha(13) and RhoA. J Biol Chem 276: 45979-45987, 2001.
24. Sordella R, Classon M, Hu KQ, Matheson SF, Brouns MR, Fine B, Zhang L, Takami H, Yamada Y, and Settleman J. Modulation of CREB activity by the Rho GTPase regulates cell and organism size during mouse embryonic development. Dev Cell 2: 553-565, 2002.
25. Steagall WK, Elmer HL, Brady KG, and Kelley TJ. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression. Am J Respir Cell Mol Biol 22: 45-50, 2000.
26. Utech M, Hobbel G, Rust S, Reinecke H, Assmann G, and Walter M. Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem Biophys Res Commun 280: 229-236, 2001.
27. Valdez BC, Henning D, Perlaky L, Busch RK, and Busch H. Cloning and characterization of Gu/RH-II binding protein. Biochem Biophys Res Commun 234: 335-340, 1997.
28. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, and Blackwell TS. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 23: 396-403, 2000.
29. - channel function. Am J Physiol Lung Cell Mol Physiol 281: L71-L78, 2001.
30. Welsh MJ, Tsui LC, Boat TF, and Beaudet AL. Cystic fibrosis. In: The Metabolic and Molecular Basis of Inherited Disease(7th ed.), edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 1995, p. 3799-3863.
31. Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, and Whitsett JA. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem 278: 7674-7682, 2003.
32. Yamamoto T, Takeda K, Harada S, Nakata T, Azuma A, Sasaki S, and Nakagawa M. HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway. Atherosclerosis 166: 213-222, 2003.
33. Zhao D, Kuhnt-Moore S, Zeng H, Pan A, Wu JS, Simeonidis S, Moyer MP, and Pothoulakis C. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves Rho family small GTPases. Biochem J 368: 665-672, 2002.